Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Acknowledgment

Acknowledgment Am J Cardiovasc Drugs 2005; 5 (6): 349-350 ACKNOWLEDGMENT 1175-3277/05/0006-0349/$34.95/0 © 2005 Adis Data Information BV. All rights reserved. Dear Readers, We hope that you have enjoyed the articles published in the American Journal of Cardiovascular Drugs in 2005. We are pleased to have been able to provide such varied and topical articles. The forward program for 2006 looks set to ensure the provision of similarly up-to-date and high-interest information, including articles on potential for pharmacological intervention in the atherosclerotic process in diabetic patients, inhibition of the renin-angiotensin-aldosterone system in the prevention of stroke, and pharmacological prevention of cardiovascular disease in the 21st Century. As always, we would be pleased to consider any high-quality review and original clinical research articles that you submit to us to supplement our program of invited articles. We would like to take this opportunity to thank all of the authors who have contributed articles to the American Journal of Cardiovascular Drugs during the past 12 months. They have generously set aside time in their busy schedules to prepare articles for the journal, and their willingness to contribute is very much appreciated. The quality of published articles reflects also the significant input of the peer http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Acknowledgment

American Journal of Cardiovascular Drugs , Volume 5 (6) – Aug 20, 2012
Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/acknowledgment-gw8KuIwDEy

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2005 by Adis Data Information BV
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.2165/00129784-200505060-00001
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs 2005; 5 (6): 349-350 ACKNOWLEDGMENT 1175-3277/05/0006-0349/$34.95/0 © 2005 Adis Data Information BV. All rights reserved. Dear Readers, We hope that you have enjoyed the articles published in the American Journal of Cardiovascular Drugs in 2005. We are pleased to have been able to provide such varied and topical articles. The forward program for 2006 looks set to ensure the provision of similarly up-to-date and high-interest information, including articles on potential for pharmacological intervention in the atherosclerotic process in diabetic patients, inhibition of the renin-angiotensin-aldosterone system in the prevention of stroke, and pharmacological prevention of cardiovascular disease in the 21st Century. As always, we would be pleased to consider any high-quality review and original clinical research articles that you submit to us to supplement our program of invited articles. We would like to take this opportunity to thank all of the authors who have contributed articles to the American Journal of Cardiovascular Drugs during the past 12 months. They have generously set aside time in their busy schedules to prepare articles for the journal, and their willingness to contribute is very much appreciated. The quality of published articles reflects also the significant input of the peer

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: Aug 20, 2012

There are no references for this article.